
ATIVIDADES COM PARTICIPAÇÃO DA INDÚSTRIA
A seguir, apresentamos atividades científicas inovadoras com o apoio da indústria, abordando os temas mais relevantes da cardiologia intervencionista na atualidade.
Inscrições para o SOLACI-SOCIME 2025
*Todos os simpósios patrocinados ocorrerão das 13h30 às 14h30.
*Informações preliminares.
QUARTA-FEIRA, 6 DE AGOSTO
01.30 pm - Main Arena

LUNCH SYMPOSIUM. MERIL. TAVR |
 | 10' | Lifetime management of patients with TAVI |
 | 10' | Landmark Updates and Deepdive |
 | 10' | My Experience with Myval Octacor (Complicated Case Presentation) |
 | 10' | Compare TAVI Update |
 | 10' | Discussion |
01.30 pm - Sala A1

How OCT and the Ultreon 2.0 imaging software can help you perform PCI in Calcified Lesions |
 | 10' | Unlocking the Power of Ultreon 2.0. |
 | 10' | Seeing the Unseen: OCT in Calcium Detection and Treatment Planning |
 | 10' | Clinical Case Illustration |
 | 10' | Clinical Case Illustration |
 | 10' | Discussion |
01.30 pm - Sala A3

Optimal Strategies for Complex PCI with APT Medical |
 | 15' | Two scenarios, one goal: Effective revascularization techniques in complex anatomies |
 | 15' | Anyreach, anywhere: From Workhorse to complex PCI |
 | 15' | Dual lumen microcatheter in complex scenarios: CTO and reverse wiring |
 | 15' | Discussion |
QUINTA-FEIRA, 7 DE AGOSTO
01.30 pm - Sala A1

Transforming PE Care: Treating with a Lytic Free Approach and Large-Bore Mechanical Thrombectomy |
 | 5' | Welcome and Opening Remarks |
 | 15' | Why Intervene: The clinical case for mechanical thrombectomy in PE |
 | 15' | From Diagnosis to Treatment: A practical approach to treating patients with large-bore device, FlowTriever |
 | 15' | Driving better outcomes through program building and multidisciplinary collaboration |
 | 10' | Q&A Panel Session |
01.30 pm - Sala A2

P-Valve in Focus: A Decade of Evolving Solutions for RVOT Dysfunction |
 | 12' | Advanced Imaging in PPVI: Optimizing Outcomes |
 | 12' | A-to-Z with P-Valve-The TPVI Procedure |
 | 12' | Built to Last: P-Valve in Complex TPVI |
 | 12' | VenusP – A Decade of Data and the Road Ahead |
 | 12' | Discussion |
01.30 pm - Sala A3

Transforming PCI: Mastering the implementation of drug-eluting balloons (DEB) |
 | | Welcome & Framing |
 | | The Evidence Base. Rationale and key clinical trials supporting DEBs |
 | | Clinical Applications. Use in standard vs. complex lesions |
 | | Mechanistic Rationale. Drug delivery, vessel healing, and drug choice |
 | | Comparative Perspectives. DEBs vs. stents: when to choose what |
 | | Panel Q&A |
 | | Closing Remarks |
01.30 pm - Sala B1

Tricuspid Regurgitation: The Forgotten Valve No More! |
 | 3' | Welcome |
 | 20' | The Rise of a Disruptive Technology |
 | 10' | Latest Evidence and Key Clinical Cases |
 | | Expert Panel: Case Discussion and Clinical Insights |
 | 10' | Case 1 |
 | 10' | Case 2 |
 | 3' | Audience Q&A |
 | 4' | Session Closure |
01.30 pm - Sala B2

The Interventional Cardiology. State of mind based on clinical cases discussion |
 | 25' | Feasibility of coronary access post TAVI is based on bioprosthetic design: Myth or Fact? |
 | 25' | Understanding the technique of PCI with DCB: Should we change our approach and expectations? |
 | 10' | Discussion |
SEXTA-FEIRA, 8 DE AGOSTO
02.00 pm - MAIN ARENA

VENUS Medtech Aortic Portfolio: Innovation, Clinical Data & Global Adoption |
 | 3' | Welcome and Opening Remarks |
 | 8' | Venus Aortic Portfolio & A-Pro Clinical Insights |
 | 8' | PowerX: A New Era in TAVI Technology and LATAM Clinical Experience |
 | 8' | Vitae Valve: Clinical Advantages & Operator Perspective |
 | 25' | Live Case from Chile Instituto Nacional : PowerX - a Noval Fully Retrievable Self-Expanding Dry-Tissue Valve |
 | 5' | Panel Discussion and Q&A |
 | 3' | Closing Remarks |